Appreciate your videos! On ergogenics, good choice on ones to high light, those are still relevant. AAS are used at supratherapeutic doses, so I agree that we can't really equate side effects from clinical trials or therapeutic use, but must ask patients directly, or read reddit forums and social media to understand trends. Great that you're reviewing this topic here, which isn't generally covered in schools for healthcare professionals. BPC-157 is currently prohibited status, as with any S0. Keep up the great work!
Appreciate your videos! On ergogenics, good choice on ones to high light, those are still relevant. AAS are used at supratherapeutic doses, so I agree that we can't really equate side effects from clinical trials or therapeutic use, but must ask patients directly, or read reddit forums and social media to understand trends. Great that you're reviewing this topic here, which isn't generally covered in schools for healthcare professionals. BPC-157 is currently prohibited status, as with any S0.
Keep up the great work!